Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Gastrointestinal Endoscopy|November 26, 2016
Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screeningDavid H Johnson, John B Kisiel, Kelli N Burger, et al.
Gastro Hep Advances|September 17, 2024
Clinical and Radiographic Characteristics in Segmental Colitis Associated With Diverticulosis, Diverticulitis, and Crohn's DiseaseSiri A Urquhart, Matthew W Ewy, Kristina T Flicek, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 4, 2009
Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?Seth Sweetser, Michael Camilleri, Sara J Linker Nord, et al.
Mayo Clinic Proceedings|June 2, 2011
Colonic polyposis and neoplasia in Cowden syndromePeter P Stanich, Victoria L Owens, Seth Sweetser, et al.
Inflammatory Bowel Diseases|February 22, 2023
The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel DiseaseSiri A Urquhart, Bryce P Comstock, Mauricio F Jin, et al.
Journal of Alzheimer'S Disease : JAD|November 20, 2014
Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous systemKendra L Puig, Brianna M Lutz, Siri A Urquhart, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 27, 2008
Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjectsSeth Sweetser, Irene A Busciglio, Michael Camilleri, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 7, 2022
Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal StudyThomas F Imperiale, Philip T Lavin, Tara N Marti, et al.
Mayo Clinic Proceedings|May 6, 2017
Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer ScreeningLila J Finney Rutten, Robert M Jacobson, Patrick M Wilson, et al.
Gastro Hep Advances|April 20, 2026
Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing CholangitisSiri A Urquhart, Prajith Raj Ramesh, Sunanda V Kane, et al.
Pageof 5